Purpose: Acute pulmonary embolism (PE) remains a significant cause of morbidity and
requires prompt diagnosis and management. While non-surgical approaches have …

Background Integrating newly developed tests and treatments for severe pulmonary
embolism (PE) into clinical care requires coordinated multispecialty collaboration. To meet …

Surgical pulmonary embolectomy (SPE) is a viable treatment approach for subsets of
patients with acute pulmonary embolism. However, outcomes data are limited. We sought to …

Massive pulmonary embolism (PE) is a severe condition that can potentially lead to death
caused by right ventricular (RV) failure and the consequent cardiogenic shock. Despite the …

Objective Systemic inflammatory response and pro‐coagulator factors are critical in acute
pulmonary embolism. Recently, there is increasing evidence that the multi‐inflammatory …

Background: Pulmonary embolism (PE) is the third most common potentially life‑threatening
cardiovascular disease. A new approach of pulmonary embolism response teams (PERTs) …

Background Venous thromboembolism (VTE) and its resulting sequelae (pulmonary
embolism [PE], chronic thromboembolic pulmonary hypertension [CTEPH], postthrombotic …

An increasing number of studies have suggested that oxidative stress and inflammation play
momentous roles in acute pulmonary embolism (APE). Honokiol, a bioactive biphenolic …

Objective Severe pulmonary embolism is often managed with thrombolysis. We sought to
determine whether endobronchial ultrasound (EBUS)-guided transbronchial thrombolysis …

Pulmonary embolism response teams (PERTs) have recently been developed to streamline
care for patients with life-threatening pulmonary embolism (PE). PERTs are unique among …